medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2019, Number 1

<< Back Next >>

Ann Hepatol 2019; 18 (1)

The Role of the CLIF-C OF and the 2016 MELD in Prognosis of Cirrhosis with and without Acute-on-Chronic Liver Failure

Perdigoto DN, Figueiredo P, Tomé L

Language: English
References: 23
Page: 48-57
PDF size: 171.75 Kb.


ABSTRACT

Introduction and aim. Acute-on-chronic liver failure (ACLF) is defined by the development of acute deterioration of liver function associated with failure of other organs and high short-term mortality in patients with chronic liver disease (CLD). There is no consensus on the diagnostic criteria, and its independence from ordinary decompensation of CLD has frequently been questioned. This study aimed to identify and characterize this condition and to test the CLIF-C OF score comparing it to the 2016-MELD (with sodium) and the Child-Pugh. Material and methods. 18-month prospective observational study with systematic inclusion of admitted patients with CLD decompensation. Results. 39 patients had ACLF (33.1%). These patients experienced higher 28-day and 90-day mortality, when compared to patients without ACLF (43.6% and 64.1% vs. 2.5% and 7.6% respectively, p ‹ 0.0001). ACLF was linked with a higher acute infection rate (74.4%). For all patients (N = 118), the scores 2016-MELD, CLIF-C OF and Child-Pugh showed an area under the curve (AUC) for 28-day mortality of 0.908, 0.844, 0.753 and for 90-day of 0.902, 0.814, 0.724 respectively, p ‹ 0.0001 for all scores. The 90-day mortality 2016-MELD AUC was greater than the CLIF-C OF AUC, p = 0.021. Within ACLF patients, the 2016-MELD, CLIF-C ACLF and Child-Pugh scores showed an AUC of 0.774, 0.734, 0.584 (28-day) and 0.880, 0.771, 0.603 (90-day); for 2016-MELD p = 0.004 (28-day) and p ‹ 0.0001 (90-day). Conclusion. ACLF is a frequent and relevant condition, associated with high mortality. The CLIF-C OF score revealed good accuracy and diagnoses ACLF when it is present. However, the 2016-MELD performed better for 90-day mortality prediction.


REFERENCES

  1. Jalan R, Gines P, Olson J, Mookerjee R, Moreau R, Garcia- Tsao G, Arroyo V, et al. Acute-on-chronic liver failure. J Hepatol 2012; 57: 1336-48.

  2. Singh H, Pai C. Defining acute-on-chronic liver failure: East, West or Middle ground? World J Hepatol 2015; 7: 2571-7.

  3. Wlodzimirow KA, Eslami S, Abu-Hanna A, Nieuwoudt M, Chamuleau RA. A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality. Liver Int 2013; 33: 40-52.

  4. Asrani S, Simonetto D, Kamath P. Acute-on-chronic liver failure. Clinical Gastroenterol Hepatol 2015; 13: 2128-39.

  5. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, et al. Acute-on-Chronic Liver Failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144: 1426-37.

  6. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure. Intensive Care Med 1996; 22: 707-10.

  7. Jalan R, Saliba F, Pavesi M, Amoros M, Moreau R, Ginès P, Levesque E, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol 2014; 61: 1038-47.

  8. Jalan R, Pavesi M, Saliba F, Amorós A, Fernandez J, Holland- Fischer P, Sawhney R, et al. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. J Hepatol 2015; 62: 831-40.

  9. Kamath P, Wiesner R, Malinchoc M, Kremers W, Therneu T, Kosberg C, D’Amico G, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.

  10. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, et al. Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-6. 11 Biggins S, Kim R, Terrault NA, Saab S, Balan V, Schiano T, Benson J, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130: 1652-60.

  11. Kim W, Biggins S, Kremers W, Wiesner R, Kamath P, Benson J, Edwards E, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-26.

  12. Xiol X, Gines P, Castells L, Twose J, Ribalta A, Fuentes-Arderiu X, Rodriguez S, et al. Clinically relevant differences in the model for end-stage liver disease and model for endstage liver disease-sodium scores determined at three university- based laboratories of the same area. Liver Transpl 2009; 15: 300-5.

  13. Barber K, Madden S, Allen J, Collett D, Neuberger J, Gimson A. Elective liver transplant list mortality: development of a United Kingdom End-stage Liver Disease score. Transplantation 2011; 92: 469-76.

  14. https://optn. transplant. hrsa. gov/media/1575/ policynotice_20151101.pdf

  15. Arroyo V, Moreau R, Jalan R, Ginès P. Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis. J Hepatol 2015; 62: 131-43.

  16. Hernaez R, Solà E, Moreau R, Ginès P. Acute-on-chronic liver failure: an update. Gut 2017; 66: 541-53.

  17. Blasco-Algora S, Masegosa-Ataz J, Gutiérrez-García ML, Alonso-López S, Fernández-Rodríguez C. Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management. World J Gastroenterol 2014; 21: 12125-40.

  18. Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, Stadlbauer V, et al. Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013. J Hepatol 2014; 60: 1310-24.

  19. Gupta T, Dhiman R, Rathi S, Agrawal S, Duseja A, Taneja S, Chawla Y. Impact of hepatic and extrahepatic insults on the outcome of Acute-on-Chronic Liver Failure. J Clin Exp Hepatol 2017; 7: 9-15.

  20. Barosa R, Roque-Ramos L, Patita M, Nunes G, Fonseca J. CLIF-C ACLF score is a better mortality predictor than MELD, MELD-Na and CTP in patients with acute on chronic liver failure admitted to the ward. Rev Esp Enferm Dig 2017; 109: 399-405.

  21. Peng Y, Qi X, Guo X. Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Medicine 2016; 95: e2877.

  22. Bañares R, Nevens F, Larsen F, Jalan R, Albillos A, Dollinger M, Saliba F, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-onchronic liver failure: the RELIEF trial. Hepatology 2013; 57: 1153-62.

  23. Garg V, Garg H, Khan A, Trehanpati N, Kumar A, Sharma BC, Sakhuja P, et al. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology 2012; 142: 505-12.




2020     |     www.medigraphic.com